Experiment: 2JTD

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
2	3D HNCA	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
3	3D HNCACB	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
4	3D HCCH-TOCSY	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
5	3D HNHA	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
6	3D 1H-15N NOESY	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
7	3D 1H-13C NOESY	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
8	3D H(CC) (CO) NH	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313
9	3D (H) CC (CO) NH	2.7 mM potassium chloride, 140 mM sodium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate	95% H2O/5% D2O	1	7.2	ambient	313

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
Refinement in Explicit Solvent	Linge et al,Proteins:Structure, Function and Genetics 50:496-506(2003)	CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	60
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.